Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC321814 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9928 | High Similarity | NPC85689 |
0.9928 | High Similarity | NPC211025 |
0.9928 | High Similarity | NPC185991 |
0.9787 | High Similarity | NPC212551 |
0.9787 | High Similarity | NPC164952 |
0.9787 | High Similarity | NPC130586 |
0.9787 | High Similarity | NPC302778 |
0.9718 | High Similarity | NPC174802 |
0.9712 | High Similarity | NPC121222 |
0.965 | High Similarity | NPC224076 |
0.9583 | High Similarity | NPC226245 |
0.9583 | High Similarity | NPC316618 |
0.9507 | High Similarity | NPC161224 |
0.9496 | High Similarity | NPC156461 |
0.9496 | High Similarity | NPC107374 |
0.9496 | High Similarity | NPC21448 |
0.9429 | High Similarity | NPC189068 |
0.9429 | High Similarity | NPC164665 |
0.9362 | High Similarity | NPC269827 |
0.9362 | High Similarity | NPC309832 |
0.9362 | High Similarity | NPC219313 |
0.9353 | High Similarity | NPC229974 |
0.9262 | High Similarity | NPC323091 |
0.9209 | High Similarity | NPC161659 |
0.9209 | High Similarity | NPC209525 |
0.9078 | High Similarity | NPC314152 |
0.9071 | High Similarity | NPC317821 |
0.9041 | High Similarity | NPC472816 |
0.8889 | High Similarity | NPC261595 |
0.8831 | High Similarity | NPC321458 |
0.8831 | High Similarity | NPC324033 |
0.88 | High Similarity | NPC239737 |
0.879 | High Similarity | NPC326529 |
0.8784 | High Similarity | NPC207633 |
0.8734 | High Similarity | NPC319100 |
0.8734 | High Similarity | NPC189261 |
0.8734 | High Similarity | NPC324198 |
0.8732 | High Similarity | NPC129756 |
0.8654 | High Similarity | NPC326082 |
0.8649 | High Similarity | NPC150853 |
0.8581 | High Similarity | NPC136349 |
0.8553 | High Similarity | NPC54320 |
0.8553 | High Similarity | NPC313754 |
0.8553 | High Similarity | NPC311197 |
0.8487 | Intermediate Similarity | NPC52238 |
0.8411 | Intermediate Similarity | NPC328479 |
0.8403 | Intermediate Similarity | NPC33996 |
0.8403 | Intermediate Similarity | NPC30326 |
0.8392 | Intermediate Similarity | NPC320818 |
0.8311 | Intermediate Similarity | NPC274384 |
0.8311 | Intermediate Similarity | NPC89147 |
0.8243 | Intermediate Similarity | NPC211820 |
0.8243 | Intermediate Similarity | NPC251233 |
0.8231 | Intermediate Similarity | NPC186619 |
0.8188 | Intermediate Similarity | NPC177169 |
0.8141 | Intermediate Similarity | NPC195140 |
0.8133 | Intermediate Similarity | NPC64705 |
0.8133 | Intermediate Similarity | NPC232408 |
0.8121 | Intermediate Similarity | NPC318590 |
0.8077 | Intermediate Similarity | NPC93365 |
0.8067 | Intermediate Similarity | NPC317746 |
0.8039 | Intermediate Similarity | NPC326694 |
0.8 | Intermediate Similarity | NPC324484 |
0.7963 | Intermediate Similarity | NPC290959 |
0.795 | Intermediate Similarity | NPC325906 |
0.7891 | Intermediate Similarity | NPC61198 |
0.7823 | Intermediate Similarity | NPC262926 |
0.7707 | Intermediate Similarity | NPC321052 |
0.7665 | Intermediate Similarity | NPC313897 |
0.7654 | Intermediate Similarity | NPC14590 |
0.7635 | Intermediate Similarity | NPC319221 |
0.7568 | Intermediate Similarity | NPC324009 |
0.7457 | Intermediate Similarity | NPC24589 |
0.7429 | Intermediate Similarity | NPC78941 |
0.7429 | Intermediate Similarity | NPC282458 |
0.7355 | Intermediate Similarity | NPC315642 |
0.7355 | Intermediate Similarity | NPC74306 |
0.7232 | Intermediate Similarity | NPC313514 |
0.7202 | Intermediate Similarity | NPC33382 |
0.716 | Intermediate Similarity | NPC125659 |
0.716 | Intermediate Similarity | NPC168702 |
0.7076 | Intermediate Similarity | NPC222174 |
0.6964 | Remote Similarity | NPC321393 |
0.6952 | Remote Similarity | NPC276373 |
0.6915 | Remote Similarity | NPC5802 |
0.6878 | Remote Similarity | NPC157821 |
0.6871 | Remote Similarity | NPC327579 |
0.6832 | Remote Similarity | NPC107160 |
0.6732 | Remote Similarity | NPC21461 |
0.6667 | Remote Similarity | NPC476564 |
0.6667 | Remote Similarity | NPC57279 |
0.6645 | Remote Similarity | NPC104011 |
0.6645 | Remote Similarity | NPC246193 |
0.6635 | Remote Similarity | NPC158055 |
0.6571 | Remote Similarity | NPC87981 |
0.6571 | Remote Similarity | NPC174114 |
0.6567 | Remote Similarity | NPC250178 |
0.6536 | Remote Similarity | NPC248007 |
0.6438 | Remote Similarity | NPC312187 |
0.6438 | Remote Similarity | NPC4837 |
0.6359 | Remote Similarity | NPC103388 |
0.634 | Remote Similarity | NPC139776 |
0.6329 | Remote Similarity | NPC287876 |
0.6266 | Remote Similarity | NPC14330 |
0.6256 | Remote Similarity | NPC160666 |
0.6207 | Remote Similarity | NPC18335 |
0.6185 | Remote Similarity | NPC472834 |
0.6051 | Remote Similarity | NPC109322 |
0.5974 | Remote Similarity | NPC68938 |
0.5914 | Remote Similarity | NPC164845 |
0.5886 | Remote Similarity | NPC5707 |
0.5882 | Remote Similarity | NPC313547 |
0.5882 | Remote Similarity | NPC217656 |
0.5848 | Remote Similarity | NPC89139 |
0.5833 | Remote Similarity | NPC296437 |
0.5813 | Remote Similarity | NPC180493 |
0.5799 | Remote Similarity | NPC470266 |
0.5769 | Remote Similarity | NPC189314 |
0.5747 | Remote Similarity | NPC244700 |
0.5743 | Remote Similarity | NPC476561 |
0.5731 | Remote Similarity | NPC476528 |
0.5731 | Remote Similarity | NPC476433 |
0.5699 | Remote Similarity | NPC265111 |
0.5698 | Remote Similarity | NPC474986 |
0.5698 | Remote Similarity | NPC476013 |
0.5698 | Remote Similarity | NPC476522 |
0.5698 | Remote Similarity | NPC476520 |
0.5698 | Remote Similarity | NPC472833 |
0.569 | Remote Similarity | NPC476408 |
0.5665 | Remote Similarity | NPC476521 |
0.5654 | Remote Similarity | NPC473585 |
0.5629 | Remote Similarity | NPC119133 |
0.5604 | Remote Similarity | NPC472832 |
0.5604 | Remote Similarity | NPC18308 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC321814 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9928 | High Similarity | NPD283 | Approved |
0.9787 | High Similarity | NPD242 | Approved |
0.9787 | High Similarity | NPD338 | Approved |
0.9718 | High Similarity | NPD339 | Approved |
0.965 | High Similarity | NPD169 | Phase 2 |
0.9496 | High Similarity | NPD250 | Approved |
0.9496 | High Similarity | NPD249 | Approved |
0.9362 | High Similarity | NPD186 | Discovery |
0.9362 | High Similarity | NPD195 | Approved |
0.9078 | High Similarity | NPD185 | Approved |
0.898 | High Similarity | NPD3107 | Discontinued |
0.898 | High Similarity | NPD1369 | Phase 2 |
0.898 | High Similarity | NPD1750 | Clinical (unspecified phase) |
0.8951 | High Similarity | NPD166 | Approved |
0.8936 | High Similarity | NPD193 | Suspended |
0.8889 | High Similarity | NPD247 | Clinical (unspecified phase) |
0.88 | High Similarity | NPD2624 | Phase 2 |
0.88 | High Similarity | NPD1732 | Phase 3 |
0.88 | High Similarity | NPD2646 | Discontinued |
0.8766 | High Similarity | NPD7988 | Suspended |
0.8734 | High Similarity | NPD4171 | Clinical (unspecified phase) |
0.8679 | High Similarity | NPD1412 | Clinical (unspecified phase) |
0.8581 | High Similarity | NPD548 | Clinical (unspecified phase) |
0.8571 | High Similarity | NPD3083 | Approved |
0.8571 | High Similarity | NPD4716 | Approved |
0.8553 | High Similarity | NPD217 | Approved |
0.8553 | High Similarity | NPD216 | Approved |
0.8553 | High Similarity | NPD219 | Phase 3 |
0.8553 | High Similarity | NPD220 | Clinical (unspecified phase) |
0.8553 | High Similarity | NPD218 | Approved |
0.8519 | High Similarity | NPD4744 | Clinical (unspecified phase) |
0.8355 | Intermediate Similarity | NPD214 | Approved |
0.8355 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.8354 | Intermediate Similarity | NPD2647 | Phase 3 |
0.8313 | Intermediate Similarity | NPD6417 | Clinical (unspecified phase) |
0.8214 | Intermediate Similarity | NPD2631 | Clinical (unspecified phase) |
0.8214 | Intermediate Similarity | NPD2632 | Approved |
0.8214 | Intermediate Similarity | NPD2630 | Approved |
0.8169 | Intermediate Similarity | NPD248 | Discontinued |
0.8099 | Intermediate Similarity | NPD9633 | Phase 3 |
0.8098 | Intermediate Similarity | NPD5666 | Phase 2 |
0.8077 | Intermediate Similarity | NPD546 | Clinical (unspecified phase) |
0.8067 | Intermediate Similarity | NPD7158 | Phase 1 |
0.8042 | Intermediate Similarity | NPD9632 | Phase 3 |
0.8014 | Intermediate Similarity | NPD9408 | Phase 3 |
0.795 | Intermediate Similarity | NPD1777 | Approved |
0.795 | Intermediate Similarity | NPD1776 | Approved |
0.7902 | Intermediate Similarity | NPD870 | Clinical (unspecified phase) |
0.7891 | Intermediate Similarity | NPD252 | Clinical (unspecified phase) |
0.7806 | Intermediate Similarity | NPD3085 | Phase 1 |
0.7799 | Intermediate Similarity | NPD4074 | Clinical (unspecified phase) |
0.7765 | Intermediate Similarity | NPD1692 | Approved |
0.7756 | Intermediate Similarity | NPD3086 | Phase 3 |
0.7702 | Intermediate Similarity | NPD516 | Clinical (unspecified phase) |
0.7682 | Intermediate Similarity | NPD549 | Approved |
0.7674 | Intermediate Similarity | NPD5684 | Clinical (unspecified phase) |
0.7674 | Intermediate Similarity | NPD5682 | Phase 3 |
0.7674 | Intermediate Similarity | NPD5683 | Clinical (unspecified phase) |
0.7584 | Intermediate Similarity | NPD194 | Clinical (unspecified phase) |
0.7566 | Intermediate Similarity | NPD3695 | Approved |
0.7566 | Intermediate Similarity | NPD3696 | Approved |
0.7543 | Intermediate Similarity | NPD4054 | Clinical (unspecified phase) |
0.7484 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.7355 | Intermediate Similarity | NPD582 | Approved |
0.7261 | Intermediate Similarity | NPD171 | Discontinued |
0.725 | Intermediate Similarity | NPD3708 | Phase 2 |
0.7232 | Intermediate Similarity | NPD7138 | Phase 2 |
0.7205 | Intermediate Similarity | NPD353 | Discontinued |
0.7197 | Intermediate Similarity | NPD4240 | Approved |
0.7175 | Intermediate Similarity | NPD1063 | Phase 2 |
0.7055 | Intermediate Similarity | NPD231 | Clinical (unspecified phase) |
0.7021 | Intermediate Similarity | NPD2965 | Clinical (unspecified phase) |
0.6984 | Remote Similarity | NPD2876 | Phase 3 |
0.6984 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.6951 | Remote Similarity | NPD9605 | Phase 3 |
0.6918 | Remote Similarity | NPD9606 | Approved |
0.6911 | Remote Similarity | NPD2824 | Phase 2 |
0.6888 | Remote Similarity | NPD5080 | Phase 2 |
0.6871 | Remote Similarity | NPD9607 | Approved |
0.6837 | Remote Similarity | NPD5079 | Phase 2 |
0.6836 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.6769 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.6769 | Remote Similarity | NPD2902 | Phase 2 |
0.6731 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.6711 | Remote Similarity | NPD9409 | Discontinued |
0.6667 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD4495 | Phase 1 |
0.6635 | Remote Similarity | NPD6840 | Approved |
0.6599 | Remote Similarity | NPD9374 | Approved |
0.659 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.6585 | Remote Similarity | NPD1730 | Discontinued |
0.6575 | Remote Similarity | NPD9373 | Approved |
0.6561 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.6536 | Remote Similarity | NPD9084 | Phase 2 |
0.6533 | Remote Similarity | NPD307 | Approved |
0.6497 | Remote Similarity | NPD282 | Approved |
0.6478 | Remote Similarity | NPD1119 | Phase 2 |
0.6407 | Remote Similarity | NPD775 | Approved |
0.6364 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.6341 | Remote Similarity | NPD1430 | Approved |
0.6341 | Remote Similarity | NPD1431 | Approved |
0.6341 | Remote Similarity | NPD2253 | Discontinued |
0.6329 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.6312 | Remote Similarity | NPD1058 | Discontinued |
0.6312 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.6277 | Remote Similarity | NPD207 | Discontinued |
0.6267 | Remote Similarity | NPD9584 | Phase 2 |
0.6256 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.6256 | Remote Similarity | NPD4458 | Phase 2 |
0.625 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.6207 | Remote Similarity | NPD8836 | Approved |
0.6203 | Remote Similarity | NPD1127 | Approved |
0.6203 | Remote Similarity | NPD1128 | Approved |
0.6178 | Remote Similarity | NPD281 | Approved |
0.6159 | Remote Similarity | NPD1808 | Phase 1 |
0.6159 | Remote Similarity | NPD799 | Phase 1 |
0.6106 | Remote Similarity | NPD6381 | Phase 2 |
0.6098 | Remote Similarity | NPD6112 | Approved |
0.6084 | Remote Similarity | NPD1118 | Discontinued |
0.6081 | Remote Similarity | NPD9416 | Phase 3 |
0.6081 | Remote Similarity | NPD9417 | Phase 3 |
0.6067 | Remote Similarity | NPD9375 | Discontinued |
0.6051 | Remote Similarity | NPD798 | Discontinued |
0.6037 | Remote Similarity | NPD1120 | Approved |
0.6037 | Remote Similarity | NPD1121 | Approved |
0.6037 | Remote Similarity | NPD535 | Approved |
0.603 | Remote Similarity | NPD4713 | Clinical (unspecified phase) |
0.603 | Remote Similarity | NPD4714 | Approved |
0.603 | Remote Similarity | NPD34 | Approved |
0.603 | Remote Similarity | NPD4715 | Clinical (unspecified phase) |
0.5986 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.598 | Remote Similarity | NPD5486 | Discontinued |
0.5978 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.5976 | Remote Similarity | NPD9484 | Clinical (unspecified phase) |
0.5945 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.5938 | Remote Similarity | NPD515 | Phase 1 |
0.5917 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.5906 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.5902 | Remote Similarity | NPD9582 | Phase 3 |
0.5893 | Remote Similarity | NPD8250 | Phase 2 |
0.5891 | Remote Similarity | NPD5458 | Discontinued |
0.5888 | Remote Similarity | NPD691 | Discontinued |
0.5886 | Remote Similarity | NPD8830 | Phase 3 |
0.5862 | Remote Similarity | NPD2452 | Phase 2 |
0.5862 | Remote Similarity | NPD2453 | Phase 2 |
0.5862 | Remote Similarity | NPD2451 | Phase 2 |
0.5862 | Remote Similarity | NPD2450 | Phase 2 |
0.5849 | Remote Similarity | NPD6036 | Suspended |
0.5844 | Remote Similarity | NPD9406 | Approved |
0.5829 | Remote Similarity | NPD7842 | Phase 2 |
0.5813 | Remote Similarity | NPD9544 | Approved |
0.5813 | Remote Similarity | NPD78 | Approved |
0.5784 | Remote Similarity | NPD796 | Phase 2 |
0.5769 | Remote Similarity | NPD8833 | Approved |
0.5769 | Remote Similarity | NPD8831 | Approved |
0.5742 | Remote Similarity | NPD757 | Phase 3 |
0.5732 | Remote Similarity | NPD9360 | Approved |
0.5708 | Remote Similarity | NPD537 | Phase 2 |
0.5708 | Remote Similarity | NPD534 | Phase 2 |
0.5708 | Remote Similarity | NPD5627 | Approved |
0.5672 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.5669 | Remote Similarity | NPD1368 | Approved |
0.5658 | Remote Similarity | NPD6351 | Discovery |
0.565 | Remote Similarity | NPD3849 | Clinical (unspecified phase) |
0.5644 | Remote Similarity | NPD1775 | Approved |
0.5644 | Remote Similarity | NPD1085 | Approved |
0.5634 | Remote Similarity | NPD4555 | Clinical (unspecified phase) |
0.5633 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.5629 | Remote Similarity | NPD9291 | Approved |
0.5628 | Remote Similarity | NPD5768 | Phase 2 |
0.5625 | Remote Similarity | NPD2221 | Clinical (unspecified phase) |
0.5611 | Remote Similarity | NPD1017 | Clinical (unspecified phase) |
0.5607 | Remote Similarity | NPD9704 | Approved |
0.5602 | Remote Similarity | NPD9650 | Phase 3 |
PubChem CID   | 440142 |
ChEMBL   | CHEMBL583986 |
ZINC   |
Molecular Weight:   | 346.08 |
ALogP:   | -2.6099 |
MLogP:   | 1.13 |
XLogP:   | -3.534 |
# Rotatable Bonds:   | 9 |
Polar Surface Area:   | 201.67 |
# H-Bond Aceptor:   | 12 |
# H-Bond Donor:   | 5 |
# Rings:   | 3 |
# Heavy Atoms:   | 23 |